Skip to content

Scholar Rock SRRK Change in Other Assets

Change in Other Assets at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
-$1.18M-107%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$6.38M+282%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.84M+184%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.85M+3,770%
Arrowhead Research logo
Arrowhead ResearchARWR
$13.18M+2,127%
Roivant Sciences logo
Roivant SciencesROIV
$1.85M-15.3%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's change in other assets?
Scholar Rock (SRRK) reported change in other assets of $37K in Q1 2026.
How has Scholar Rock's change in other assets changed year-over-year?
Scholar Rock's change in other assets increased by 142.0% year-over-year, from -$88K to $37K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.